Norges Bank Meridian Bioscience Inc Transaction History

Norges Bank

  • $772 Billion
  • Q2 2025

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
N/A
-245,000 Closed
0 $0
Q4 2022

Feb 14, 2023
BUY
$31.15 - $33.39 $12.5 Million - $13.4 Million
400,400 New
400,400 $13.3 Million
Q3 2022

Nov 13, 2023
BUY
$30.9 - $33.55 $7.57 Million - $8.22 Million
245,000 New
245,000 $7.72 Million
Q1 2021

May 07, 2021
SELL
$19.76 - $29.89 $3.36 Million - $5.08 Million
-169,903 Closed
0 $0
Q4 2020

Mar 02, 2021
BUY
$15.73 - $21.66 $2.67 Million - $3.68 Million
169,903 New
169,903 $3.18 Million
Q4 2020

Feb 10, 2021
SELL
$15.73 - $21.66 $2.67 Million - $3.68 Million
-169,903 Closed
0 $0
Q3 2020

Nov 12, 2021
BUY
$13.54 - $26.41 $2.3 Million - $4.49 Million
169,903 New
169,903 $2.89 Million
Q3 2020

Nov 10, 2020
SELL
$13.54 - $26.41 $3.81 Million - $7.42 Million
-281,050 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$7.84 - $23.29 $2.2 Million - $6.55 Million
281,050 New
281,050 $6.55 Million
Q2 2020

Aug 07, 2020
SELL
$7.84 - $23.29 $2.2 Million - $6.55 Million
-281,050 Closed
0 $0
Q1 2020

May 07, 2021
BUY
$5.57 - $11.5 $1.57 Million - $3.23 Million
281,050 New
281,050 $2.36 Million
Q1 2020

May 08, 2020
SELL
$5.57 - $11.5 $1.57 Million - $3.23 Million
-281,050 Closed
0 $0
Q4 2019

Mar 03, 2020
BUY
$7.9 - $10.14 $2.22 Million - $2.85 Million
281,050 New
281,050 $2.75 Million
Q4 2019

Feb 12, 2020
SELL
$7.9 - $10.14 $5.67 Million - $7.28 Million
-718,054 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$9.17 - $12.01 $6.58 Million - $8.62 Million
718,054 New
718,054 $6.81 Million
Q3 2019

Nov 08, 2019
SELL
$9.17 - $12.01 $10.1 Million - $13.2 Million
-1,096,918 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$10.88 - $17.6 $11.9 Million - $19.3 Million
1,096,918 New
1,096,918 $13 Million
Q2 2019

Aug 09, 2019
SELL
$10.88 - $17.6 $13.8 Million - $22.4 Million
-1,270,257 Closed
0 $0
Q4 2018

Mar 04, 2019
BUY
$14.52 - $19.72 $18.4 Million - $25 Million
1,270,257 New
1,270,257 $22.1 Million
Q4 2018

Feb 08, 2019
SELL
$14.52 - $19.72 $18.4 Million - $25 Million
-1,270,257 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$14.85 - $16.35 $18.9 Million - $20.8 Million
1,270,257 New
1,270,257 $18.9 Million
Q3 2018

Nov 09, 2018
SELL
$14.85 - $16.35 $18.9 Million - $20.8 Million
-1,270,257 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$13.8 - $16.8 $17.5 Million - $21.3 Million
1,270,257 New
1,270,257 $20.2 Million
Q2 2018

Jul 23, 2018
SELL
$13.8 - $16.8 $15.6 Million - $19 Million
-1,131,166 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$13.8 - $16.2 $15.6 Million - $18.3 Million
1,131,166 New
1,131,166 $16.1 Million
Q1 2018

May 09, 2018
SELL
$13.8 - $16.2 $15.7 Million - $18.4 Million
-1,136,022 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$13.55 - $15.8 $15.4 Million - $17.9 Million
1,136,022 New
1,136,022 $15.9 Million
Q4 2017

Feb 09, 2018
SELL
$13.55 - $15.8 $15.4 Million - $17.9 Million
-1,136,022 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$13.45 - $14.35 $15.3 Million - $16.3 Million
1,136,022 New
1,136,022 $16.2 Million
Q3 2017

Nov 07, 2017
SELL
$13.45 - $14.35 $15.3 Million - $16.3 Million
-1,136,022 Closed
0 $0
Q3 2016

Nov 13, 2017
BUY
N/A
1,136,022
1,136,022 $0

Others Institutions Holding VIVO

# of Institutions
9
Shares Held
97.4K
Call Options Held
0
Put Options Held
0
View Full List

About MERIDIAN BIOSCIENCE INC

VIVO Quotes by TradingView
  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email